Propargyl-PEG3-acid

What We Offer

Propargyl-PEG3-acid

Propargyl-PEG3-acid | 1347760-82-0

Catalog Number R02-0008
Category Alkynes
Molecular Formula C10H16O5
Molecular Weight 216.23
Catalog Number Size Price Quantity
R02-0008 -- $--

Chemical Information

Synonyms 3-(2-(2-(Prop-2-yn-1-yloxy)ethoxy)ethoxy)propanoic acid; Propyne-PEG2-CH2CH2COOH; Alkyne-PEG3-COOH; Propargyl-PEG3-COOH; Propargyl-PEG3-Carboxylic Acid; 3-[2-[2-(2-Propyn-1-yloxy)ethoxy]ethoxy]propanoic acid; Propanoic acid, 3-[2-[2-(2-propyn-1-yloxy)ethoxy]ethoxy]-
Purity >98.0%
Shelf Life ≥ 2 years
IUPAC Name 3-[2-(2-prop-2-ynoxyethoxy)ethoxy]propanoic acid
Canonical SMILES C#CCOCCOCCOCCC(=O)O
InChI InChI=1S/C10H16O5/c1-2-4-13-6-8-15-9-7-14-5-3-10(11)12/h1H,3-9H2,(H,11,12)
InChI Key CJNSWLAJTZVSRB-UHFFFAOYSA-N
Solubility Soluble in DCM, DMF, DMSO, Water
Density 1.1±0.1 g/cm3
Appearance Light yellow to brown clear liquid
Boiling Point 348.0±32.0 °C at 760 mmHg
Vapor Pressure 0.0±1.6 mmHg at 25°C
LogP -0.44
  • Product Specification
Storage Store at -20°C, keep in dry and avoid sunlight
Signal Warning
GHS Hazard Statements H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]
Precautionary Statement Codes P264, P264+P265, P280, P302+P352, P305+P351+P338, P321, P332+P317, P337+P317, and P362+P364

Computed Properties

XLogP3 -0.6
Hydrogen Bond Donor Count 1
Hydrogen Bond Acceptor Count 5
Rotatable Bond Count 10
Exact Mass 216.09977361 g/mol
Monoisotopic Mass 216.09977361 g/mol
Topological Polar Surface Area 65Ų
Heavy Atom Count 15
Formal Charge 0
Complexity 205
Isotope Atom Count 0
Defined Atom Stereocenter Count 0
Undefined Atom Stereocenter Count 0
Defined Bond Stereocenter Count 0
Undefined Bond Stereocenter Count 0
Covalently-Bonded Unit Count 1
Compound Is Canonicalized Yes

Patents

Publication NumberTitlePriority Date
TW-201800110-A Antibody-drug conjugate based on eribulin and method of use 2016-03-02
US-2017252458-A1 Eribulin-based antibody-drug conjugates and methods of use 2016-03-02
US-2018193478-A1 Eribulin-based antibody-drug conjugates and methods of use 2016-03-02
US-2017114341-A1 Polynucleotide constructs having bioreversible and non-bioreversible groups 2014-06-06
US-2020392498-A1 Polynucleotide constructs having bioreversible and non-bioreversible groups 2014-06-06
cartIcon
Inquiry Basket